MRSA/SA is a qualitative RT-PCR test detecting and differentiating between methicillin-resistant Staphylococcus aureus (MRSA), methicillin-sensitive Staphylococcus aureus (MSSA) and methicillin-resistant coagulase-negative Staphylococci (MRCoNS). By using one single cartridge, the Vivalytic MRSA/SA test aids in the diagnosis of MRSA infection in a speedy manner so that appropriate antibiotic treatment can be applied, and complications prevented.
Vivalytic VS Traditional Culture Methods
The Vivalytic point of care device can provide fast and accurate results, crucial when it comes to treating infectious diseases like MRSA.
Additionally, with closed-system testing the Vivalytic also offers reduced risk of contamination compared to traditional culture methods. This is because it uses closed-system testing, which minimises the chances of contamination and helps ensure the accuracy of the results.
Moreover, the Vivalytic system also offers reduced time to diagnosis at 53 minutes, which is vital for effective infection control and patient care in comparison to traditional methods which can take up to 2-3 days. With faster and more accurate results, healthcare professionals can quickly isolate and treat patients with MRSA, reducing the risk of spread and improving patient outcomes.
Bacterial Differentiation to Promote Targeted Therapy
Enhances patient care by screening for sensitive or resistant Staphylococcus strains in wards, emergency settings, and before elective surgeries.
Screening reduces health risks by preventing contamination,